NIH Technical Assistance Programs - Transition to Phase III
A cornerstone of the SBIR and STTR programs is helping companies move along the path of commercialization, with an emphasis on reducing technology risk and increasing the value proposition. HHS offers the I-Corps TM at NIH program and the Niche Assessment Program for Phase I awardees, and the Commercialization Accelerator Program (CAP) for Phase II awardees.
Technologies supported by these programs include a range of drug, device, diagnostic or behavioral interventions.
NIH SBIR/STTR Niche Assessment Program (NAP)
Provides active Phase I awardees with market research, and consumer and competition analysis. Topics include: new applications for the SBIR/STTR developed technology; needs and concerns of the end-user and new markets for possible entry.
NIH SBIR/STTR Commercialization Accelerator Program (CAP)
Trains Phase II awardees on how to be market ready. Topics include: tailored market entry strategies; strategic partnerships; FDA regulatory requirements; financing strategies; investor pitches and intellectual property matters.